3
Thomas Schinecker
CEO
F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
3 leaders · Full leadership timeline
Roche is not just a drug company with a diagnostics side business. Its strategic identity is an integrated healthcare model: test the patient, identify the biology, treat with a targeted therapy, and use outcome data to improve the next development cycle.
Roche makes money from branded prescription medicines, biologics, oncology and specialty drugs, diagnostic instruments, diagnostic reagents, sequencing and molecular testing, diabetes care products, and clinical data assets. Pharmaceuticals drive the largest share of sales, while Diagnostics adds recurring reagent revenue and supports personalized healthcare.
CEO
CEO
CEO
Roche faces biosimilar erosion on older biologics, pricing pressure in the United States and Europe, clinical-trial risk in oncology and neuroscience, diagnostics pricing pressure, and the need to replace maturing blockbusters with newer medicines.